GlassScriptPhysician profile
Drew E Schnitt
NPI 1568507606
$89,341.02
in general payments reported to CMS, 2019-2025
25 companies · $1,392 in 2025
The $1,392 reported for 2025 was more than what 79% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38K · 2020: $29K · 2021: $13K · 2022: $2,057 · 2023: $3,995 · 2024: $1,444 · 2025: $1,392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,597 · Consulting Fee: $200 · Education: $33.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,596.80 |
| Consulting Fee | $200.00 |
| Education | $33.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apyx Medical Corporation | $45,029.19 | 2019-2020 | |
| Lumenis Be INC | $14,790.55 | 2021-2023 | M22 |
| Allergan, INC. | $8,688.60 | 2019-2022 | |
| Tei Biosciences INC | $7,727.05 | 2019 | |
| Lumenis, INC | $5,937.02 | 2019 | |
| Abbvie INC. | $1,822.92 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Merz North America, INC. | $1,075.18 | 2022-2024 | Xeomin |
| Tela Bio, INC. | $818.48 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Sientra, INC. | $522.02 | 2020-2022 | |
| Mentor Worldwide LLC | $501.84 | 2022-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Ethibond Excel |
| Innovation Technologies INC | $326.44 | 2020-2021 | |
| Medtronic, INC. | $325.00 | 2021-2024 | Straightshot, Indigo, Surgipro Ll |
| Motiva USA, LLC | $261.56 | 2024-2025 | |
| Galderma Laboratories, L.P. | $252.60 | 2019-2024 | |
| Davol INC. | $173.60 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $165.46 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Musculoskeletal Transplant Foundation INC. | $154.89 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $154.59 | 2020-2024 | Exparel |
| Smith+Nephew, INC. | $144.32 | 2025 | Renasys Touch, Pico 14 |
| Acelrx Pharmaceuticals, INC. | $103.59 | 2020 | |
| Coopersurgical, INC. | $100.94 | 2020-2023 | Fisherbrand Disposable Liquid Infant Heel Warmer |
| Dilon Technologies, INC. | $92.86 | 2023-2024 | Hemoblast Bellows |
| Kowa Pharmaceuticals America, INC. | $92.59 | 2023 | Seglentis |
| Eagle Pharmaceuticals, INC. | $47.98 | 2019 | |
| Solta Medical, A Division of Bausch Health US, LLC | $31.75 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Drew Schnitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.